Soluble CD26 and CD30 levels in CSF and sera of patients with relapsing neuromyelitis optica [2]

Journal of Neurology

Volumn 253, Issue 1, 2006, Pages 111-113

  Narikawa, Koichi ^a   Misu, Tatsuro ^a   Fujihara, Kazuo ^a   Nakashima, Ichiro ^a   Sato, Shigeru ^b   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOHNAN HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CORRELATION COEFFICIENT; DIAGNOSTIC APPROACH ROUTE; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; LETTER; MYELOOPTIC NEUROPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; REMISSION; TH1 CELL; TH2 CELL; UPREGULATION;

ADULT; ANTIGENS, CD26; ANTIGENS, CD30; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RECURRENCE;

EID: 31544434663     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0901-1     Document Type: Letter

References (15)

1. Gerli R, Lunardi C, Vinante F, Bistoni O, Pizzolo G, Pitzalis C (2001) Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory for Th1-driven diseases. Trends Immunol 22:72-77
2. Gorrell MD, Gysbers V, McCaughan GW (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 54:249-264
3. Khoury SJ, Guttmann CR, Orav EJ, Kikinis R, Jolesz FA, Weiner HL (2000) Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch Neurol 57:1183-1189
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2012
5. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461
6. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
7. Mcmillan SA, McDonnell GV, Douglas JP, Droogan AG, Hawkins SA (1998) Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis. Neurology 51:1156-1160
8. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama Y (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain 125:2460-2468
9. Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y (2001) Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 114:207-212
10. Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y (2004) Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology 62:144-146
11. Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y (2004) CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 149:182-186
12. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382-387
13. Sellebjerg F, Christiansen M, Jensen J, Frederiksen JL (2000) Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Eur J Neurol 7:281-289
14. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815
15. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114